Intellia Therapeutics Announces Third Quarter 2017 Financial Results – GlobeNewswire (press release)
|
Intellia Therapeutics Announces Third Quarter 2017 Financial Results
GlobeNewswire (press release) CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (Nasdaq:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR technology, announced financial and operational results for … |
